Skip to main content

Watson Pharmaceuticals gets the OK from FDA for new nicotine polacriliex gum


MORRISTOWN, N.J. Watson Pharmaceuticals, a leader in generic and specialty branded pharmaceuticals, announced its subsidiary, Watson Labs, has been granted approval from the Food and Drug Administration to market its nicotine polacrilex gum.

Nicotine polacrilex gum is the generic equivalent of GlaxoSmithKline Consumer Healthcare's Nicorette Fruit Chill and Cinnamon Surge Coated gums, all of which are available over-the-counter and used to help people stop smoking.

Watson's nicotine gum will be available as soon as possible in coated fruit and cinnamon flavors.

This ad will auto-close in 10 seconds